Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Nurix Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nurix Therapeutics Inc. May 15, 202674.2%
-
Nurix Therapeutics Inc. May 4, 202386.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 22, 2026 | Rapport Therapeutics Inc. | Open-market purchase | +3,680 | $27.08 | $99,636 |
Questions about Paul M. Silva
What boards is Paul M. Silva on?
Paul M. Silva sits on the boards of Nurix Therapeutics Inc. and Rapport Therapeutics Inc.
How long has Paul M. Silva served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.